Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endometrial Biopsy in Progestin Contraceptive Users
NCT05760144Phase 1Completed
- Sponsor
- Oregon Health & Science University
- Start
- Jul 2023
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of etonogestrel and medroxyprogesterone acetate in contraception (2 arms), sponsored by Oregon Health & Science University. Primary endpoint: Proportion of participants who experienced endometrial changes at 6 months. Started Jul 2023; status: completed.
02
Drugs
etonogestrelmedroxyprogesterone acetate
03
Conditions
contraception
Beyond the preview
Go deeper on NCT05760144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05760144.